Lifecore Biomedical Inc (LFCR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 05/31
| 11-2020 | 08-2020 | 05-2020 | 02-2020 | 11-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 2,491 | 589 | 360 | 2,607 | 1,594 |
| Receivables | 66,545 | 65,027 | 76,206 | 69,763 | 69,962 |
| Inventories | 71,202 | 59,998 | 66,311 | 67,059 | 58,563 |
| TOTAL | $154,187 | $147,367 | $157,107 | $148,811 | $140,180 |
| Non-Current Assets | |||||
| PPE Net | 170,973 | 171,413 | 192,338 | 191,782 | 204,687 |
| Investments And Advances | 45,100 | 56,900 | 56,900 | 61,300 | 61,300 |
| Intangibles | 106,498 | 106,995 | 107,491 | 120,956 | 121,468 |
| Other Non-Current Assets | 22,402 | 23,505 | 27,477 | 27,211 | 32,362 |
| TOTAL | $344,973 | $358,813 | $384,206 | $401,249 | $419,817 |
| Total Assets | $499,160 | $506,180 | $541,313 | $550,060 | $559,997 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 88,189 | 80,027 | 88,954 | 70,223 | 73,223 |
| Accounts payable and accrued liabilities | 60,892 | 50,722 | 51,647 | 63,660 | 47,145 |
| Accrued Expenses | 7,689 | 8,895 | 9,034 | 8,458 | 8,700 |
| TOTAL | $173,914 | $153,729 | $164,388 | $157,970 | $144,361 |
| Non-Current Liabilities | |||||
| Long Term Debt | 82,000 | 93,919 | 101,363 | 104,539 | 107,470 |
| Deferred Revenues | 644 | 477 | 352 | 618 | 611 |
| Other Non-Current Liabilities | 27,563 | 28,015 | 30,930 | 28,221 | 32,043 |
| TOTAL | $116,308 | $131,293 | $145,881 | $144,422 | $156,560 |
| Total Liabilities | $290,222 | $285,022 | $310,269 | $302,392 | $300,921 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 29,323 | 29,242 | N/A | 29,182 | 29,163 |
| Common Shares | 29 | 29 | 29 | 29 | 29 |
| Retained earnings | 46,944 | 60,245 | 71,245 | 86,394 | 97,912 |
| Other shareholders' equity | -2,103 | -2,504 | -2,808 | -832 | -421 |
| TOTAL | $208,938 | $221,158 | $231,044 | $247,668 | $259,076 |
| Total Liabilities And Equity | $499,160 | $506,180 | $541,313 | $550,060 | $559,997 |